All Blogs

Nov 20, 2024

Medical radiation detection devices are not just safety tools; they are integral to maintaining the delicate balance between leveraging the benefits of radiation and minimizing its risks. With radiation playing a pivotal role in diagnosing and treating life-threatening conditions such as cancer, the need for precis...

Nov 19, 2024

FDA Approves AADC Deficiency Gene Therapy by PTC Therapeutics PTC Therapeutics, Inc. has secured FDA accelerated approval for KEBILIDI (eladocagene exuparvovec-tneq), marking a historic milestone as the first-ever gene therapy directly administered to the brain in the United States. This innovative therapy addre...

Nov 22, 2024

NK cell therapies have demonstrated significant clinical efficacy, with studies reporting response rates ranging from 40% to 80% in certain hematologic malignancies. As of recent data, several NK cell therapy candidates are in clinical trials, with notable successes including improved overall survival rates and red...

Nov 18, 2024

Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It affects about 10 million people worldwide. The average age of onset for Parkinson’s disease is around 60; however, approximately 10-15% of patients experience early-onset PD before the age of 50. In 2023, there...

Nov 15, 2024

Immunotherapy has revolutionized the treatment landscape for cancer, offering hope for patients who have exhausted traditional therapeutic options. In the ever-evolving field of immunotherapy, two emerging approaches—CAR-T cells and CAR-Exosome agents—are garnering attention for their potential to revolutionize the...

Nov 14, 2024

Caris Life Sciences Received FDA Approval for MI Cancer Seek™ as a Companion Diagnostic (CDx) Test  On November 6, 2024, Caris Life Sciences, a leading next-generation AI TechBio company and precision medicine pioneer, announced that the U.S. Food and Drug Administration (FDA) approved MI Cancer Seek™ for u...

Jun 30, 2025

In today’s healthcare ecosystem, enhancing operating room efficiency is no longer optional—it’s essential. As surgical demand rises and hospital resources are stretched, hospitals are turning to operating room optimization strategies that blend clinical expertise with smart technology. The adoption of operating roo...

Nov 12, 2024

FDA Approves Autolus's AUCATZYL for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Autolus Therapeutics has achieved a significant milestone with FDA approval for AUCATZYL (obecabtagene autoleucel), a next-generation CAR T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic le...

Nov 11, 2024

In the rapidly evolving field of oncology, novel CDK7 inhibitors are emerging as game-changers, challenging the status quo of cancer treatment. By specifically targeting CDK7, these innovative therapies not only halt cancer cell proliferation but also enhance the effectiveness of existing treatments. With the abili...

Nov 08, 2024

Urinary tract infections (UTIs) are among the most prevalent bacterial infections in the US and globally. Around 60% of women will experience an uncomplicated UTI (uUTI) during their lifetime, and up to 40% of women with a history of uUTIs may face a recurrence, according to Iterum’s approval announcement. In 20...